Vaccine. 2009 Mar 26;27(15):2188-93. Epub 2009 Feb 4.

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.

Schuller E, Klade CS, Wölfl G, Kaltenböck A, Dewasthaly S, Tauber E.

Source

Intercell AG, Campus Vienna Biocenter 2, 1030 Wien, Austria.

Abstract

The standard administration of the investigational Japanese encephalitis vaccine IC51 is 2 doses of 6 microg with a 28-day interval. This study investigated the immunogenicity of a single-immunization, high-dose regimen (1 x 12 microg) compared to the 2-injection, standard regimen to determine the immune response that one, high-dose injection can confer. The single, high-dose regimen resulted in about 60% seroconversion rate (SCR) at 10 days after administration, but it did not reach the almost 100% SCR achieved by the 2-dose standard administration at Day 35. The standard regimen conferred essentially 100% seroconversion already 7 days after the second immunization.

PMID:: 19200452; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Immunization - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. [Vaccine. 2009]
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
Kaltenböck A, Dubischar-Kastner K, Eder G, Jilg W, Klade C, Kollaritsch H, Paulke-Korinek M, von Sonnenburg F, Spruth M, Tauber E, et al. Vaccine. 2009 Jul 16; 27(33):4483-9. Epub 2009 May 30.
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine. [J Infect Dis. 2008]
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
Tauber E, Kollaritsch H, von Sonnenburg F, Lademann M, Jilma B, Firbas C, Jelinek T, Beckett C, Knobloch J, McBride WJ, et al. J Infect Dis. 2008 Aug 15; 198(4):493-9.
Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age. [Vaccine. 2010]
Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.
Kaltenböck A, Dubischar-Kastner K, Schuller E, Datla M, Klade CS, Kishore TS. Vaccine. 2010 Jan 8; 28(3):834-9. Epub 2009 Oct 24.
Review Japanese encephalitis: update on vaccines and vaccine recommendations. [Curr Opin Infect Dis. 2010]
Review Japanese encephalitis: update on vaccines and vaccine recommendations.
Wilder-Smith A, Halstead SB. Curr Opin Infect Dis. 2010 Oct; 23(5):426-31.
Review Ixiaro: a new vaccine against Japanese encephalitis. [Expert Rev Vaccines. 2009]
Review Ixiaro: a new vaccine against Japanese encephalitis.
Jelinek T. Expert Rev Vaccines. 2009 Nov; 8(11):1501-11.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Comparison of a single, high-dose vaccination regimen to the standard regimen fo...
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
Vaccine. 2009 Mar 26 ;27(15):2188-93. Epub 2009 Feb 4 .

PubMed
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV...
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.
J Clin Psychiatry. 2009 Apr ;70(4):458-66. Epub 2008 Dec 30 .

PubMed
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar dep...
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
J Clin Psychiatry. 2009 Feb ;70(2):223-31. Epub 2008 Dec 30 .

PubMed
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?
J Natl Compr Canc Netw. 2009 Feb ;7(2):203-13.

PubMed
Multiple RNAs from the mouse carboxypeptidase M locus: functional RNAs or transc...
Multiple RNAs from the mouse carboxypeptidase M locus: functional RNAs or transcription noise?
BMC Mol Biol. 2009 Feb 8 ;10:7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information